Your institution may have access to this item. Find your institution then sign in to continue.
Title
Denosumab reduces fracture risk better than placebo.
Abstract
The article offers information on denosumab to prevent fractures in women with osteoporosis. It states that denosumab modestly decreases the risk of clinical fracture in postmenopausal women with osteoporosis just like bisphosphonates. However, prescription of denosumab is given to women who cannot tolerate bisphosphonates.